Using Any HPV Vaccination May Reduce Burden of Disease
Researchers suggested that the receipt of 1, 2, or 3 doses of an HPV vaccine by females aged 15 to 19 years was associated with a lower incidence of preinvasive cervical disease when compared to unvaccinated females.
Read more
ADVERTISEMENT
 
FDA Grants Priority Review to Capmatinib for Non-Small Cell Lung Cancer
The FDA granted a priority review to capmatinib, a MET inhibitor being analyzed for the first-line treatment of previously treated patients with METex14-mutated advanced NSCLC.
Read more

 
 
Patrick I. Borgen, MD, Discusses Treatment Advances to Watch for in HER2-Positive Breast Cancer

The breast cancer expert discussed 2 advances in HER2-positive breast cancer treatment that healthcare providers should look for.

Read more